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Abstract Perfusion-weighted mag-
netic resonance imaging (PWI) has
been proposed as an attractive non-
invasive tool for evaluating cerebral
haemodynamics. Quantitative maps
of cerebral blood flow (CBF), cere-
bral blood volume (CBV), mean
transit time (MTT), time to peak
(TTP) and various other haemody-
namic parameters can be obtained.
Recent advances in hard- and soft-
ware made PWI available for clinical
routine. Although PWI became 
common in adult neuroradiology, 
it remains challenging in pediatric 
neuroradiology. In this article, the
different PWI techniques that render
haemodynamic maps of the brain are
presented and discussed. The normal
developmental changes of the cere-
bral haemodynamics in children as
measured by PWI are presented as
well as the application of PWI in 
cerebral ischaemia, primary and 
secondary cerebral vasculopathies
and in cerebral tumours.
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Introduction
The cerebral circulation relies on a dynamic vascular
system that maintains a steady state delivery of blood to
the brain. Autoregulatory mechanisms are designed to
preserve an adequate, stable cerebral perfusion. The
close relationship between cerebral perfusion, metabo-
lism and neuronal function was described as early as
1890 by Roy and Sherrington [1].
Cerebral perfusion is typically measured as the quan-
tity of blood (ml) perfusing a volume of brain (100 g)
per unit of time (min), also known as cerebral blood flow
(CBF). Several additional, closely linked parameters, in-
cluding cerebral blood volume (CBV) and blood circula-
tion time, are used to characterise cerebral haemodynam-
ics. The CBV is the amount of blood in a given amount
of brain while the mean transit time (MTT) represents
the time the blood takes to pass the brain tissue. These
haemodynamic parameters are linked by the following
relationship:
(1)
Cerebral blood flow is influenced by multiple, complex
interacting factors including arterial perfusion pressure,
intracranial pressure, blood viscosity, arterial pCO2 and
pO2. Cerebral autoregulation mechanisms preserve CBF
within a narrow range to guarantee brain tissue integrity
and function. The CBF and CBV are tightly coupled
[2].
Many disease processes are known to alter cerebral
perfusion. These changes can be in either direction. Ce-
rebral perfusion can be reduced (cerebral ischaemia) or
increased (arterio-venous malformations). In addition, in
many disease processes CBF and CBV can be decou-
pled. In acute cerebral ischaemia, for example, a cerebral
vasodilatation can occur in compensation to a decreased
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perfusion pressure. This vasodilatation increases CBV,
whereas CBF remains below normal [3, 4, 5, 6].
Neuro-anatomical imaging techniques, including CT
and MRI, represent important diagnostic tools in the
evaluation of cerebrovascular disease (CVD). A major
limitation is that these techniques identify only the se-
quelae from CVD without giving detailed information
about the underlying cerebral haemodynamics. In addi-
tion, conventional CT and MRI often detect injury too
late, i.e. after injury has become irreversible. An alterna-
tive technique that gives functional, haemodynamic in-
formation is therefore desirable. This technique should
identify the aetiology and severity of the vascular pathol-
ogy, estimate the risk of future tissue injury, direct the
correct treatment, evaluate and monitor the results of
treatment and finally give insight in the pathophysiology
of disorders involving the cerebrovascular system and
haemodynamics in general.
Multiple techniques have been proposed to investi-
gate the cerebrovascular system. Some provide non-
tomographic, regional data, whereas others provide pro-
jectional or tomographic images. Imaging includes X-ray
angiography, CT angiography, MR angiography and
Doppler ultrasonography. These techniques are, howev-
er, focused on detecting blood flow in the macroscopic
vasculature, whereas most cerebrovascular diseases be-
gin at the microvascular or capillary level. The macro-
scopic vasculature is seldom involved in the early stages
of disease. Detection of pathology at the microvascular
level is consequently favourable because treatment could
be started at an earlier stage of the disease, possibly even
before irreversible clinical symptoms develop.
Techniques that provide haemodynamic information
at the capillary level include positron emission tomogra-
phy (PET), single photon emission computed tomogra-
phy (SPECT) and dynamic 133xenon CT. These methods
are, however, expensive, time-consuming and require the
administration of ionizing radiation: a distinct disadvan-
tage in children.
Perfusion-weighted MRI is a tomographic imaging
technique that combines unique features in assessing
brain perfusion. PWI is relatively sensitive to the micro-
vasculature, is minimally invasive, has a higher spatial
resolution than PET/SPECT, does not use ionizing radia-
tion and has a better contrast-to-noise per unit of time
compared with X-ray CT. In addition, MRI scanners are
more widely available than PET/SPECT scanners, PWI
can easily be added to conventional MRI (short acquisi-
tion time), and finally the faster heart rate and smaller
perfusion cross-sectional area of the child’s brain in-
crease the quality of PWI.
How is tissue perfusion measured by MRI
There are currently two fundamentally different ap-
proaches to measure brain perfusion by MRI. The first,
most widely applied method is referred to as the “dy-
namic susceptibility contrast technique”. This approach
uses long-established principles of indicator dilution
methods in which a decrease of T2 or T2* MR signal in-
tensity is related to the passage of paramagnetic contrast
materials through the capillary bed [7, 8, 9]. The drop in
MR signal intensity gives information about multiple
haemodynamic parameters.
The second, currently less often applied method relies
on the use of inversion or saturation pulses that label
blood spins before flowing into the brain slice of inter-
est. In this technique, also known as “arterial spin label-
ling” (ASL), the consequent MR signal changes are di-
rectly related to the local haemodynamics.
A third MRI technique that uses phase-sensitive se-
quences to capture MR signal changes due to perfusion-
induced intravoxel incoherent motion (IVIM) is present-
ly mainly of historical importance and is consequently
only mentioned for completeness but is not discussed in
this paper [10].
Dynamic susceptibility contrast imaging
Dynamic susceptibility contrast imaging relies on T2 or
T2* signal changes within the brain tissue due to suscep-
tibility effects of high doses of paramagnetic contrast
material flowing through the brain vasculature (Figs. 1,
2). Unlike conventional MRI, the basis of PWI does not
rely on relaxivity (dipole–dipole) effects but primarily
on magnetic susceptibility effects.
The short range at which dipole–dipole effects of para-
magnetic contrast agents (e.g. gadolinium chelates) act, re-
strict their effects upon those spins which are in direct con-
tact with the contrast agent. Because most routinely used
paramagnetic contrast agents do not cross the blood-brain
barrier (BBB), these dipole–dipole effects are consequently
limited to the intravascular space or cerebral blood pool.
This compartmentalization means that if we would rely on
these dipole–dipole effects haemodynamic maps would be
calculated from maximal 4% of the cerebral spins.
T2 and T2* weighted dynamic susceptibility contrast
imaging takes advantage of the compartmentalization.
The accumulation of high magnetic susceptibility con-
trast agents within the approximately randomly oriented
capillary network of the brain results in localized varia-
tions in tissue magnetic fields. This microscopic hetero-
geneity of magnetic field induces a loss of transverse
phase coherence with T2/T2* signal loss in the surround-
ing brain tissue (outside of the vascular compartment;
Figs. 1, 2). Magnetic susceptibility effects act on a lon-
ger range than the previously described dipole–dipole in-
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teractions; magnetic susceptibility phenomena extend
outside of the vessels for a distance roughly equal to the
radius of the blood vessels. This means that these effects
are not just limited to the blood pool but involve the en-
tire brain; more spins are affected by the passage of para-
magnetic contrast agents. By affecting more spins, a big-
ger signal change is achieved. The improved signal re-
sults in more reliable PWI maps. In addition, the haemo-
dynamic information supplied by magnetic susceptibility
PWI is more tissue perfusion weighted than T1-weighted
dipole–dipole imaging.
Basic principles of dynamic magnetic 
susceptibility imaging
Dynamic magnetic susceptibility imaging relies on the
rapid acquisition of as many images as possible during
the passage of contrast media through the brain to mea-
sure the degree of T2/T2* signal changes over time
(Figs. 1, 2, 3). Rapid and well-timed imaging is neces-
sary because magnetic susceptibility effects rely on high
concentrations of Gd, which are typically present during
the first passage of contrast agents through the capillary
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Fig. 1 Gradient-echo, echo-pla-
nar (EPI) dynamic susceptibility
contrast imaging. A series of
raw images after the injection 
of a bolus of gadolinium is dis-
played. The first four images
show the precontrast baseline
signal intensity. The arrival of
the gadolinium is first seen
within branches of the middle
cerebral artery, 6 s after contrast
injection, followed by a marked
parenchymal signal loss during
the first passage of the gadolini-
um (9–16.5 s). A phase of rapid
signal recovery is then followed
by a discrete second signal drop
due to the first recirculation of
the gadolinium (27–31.5 s). At
the end of the series, a discrete
residual signal loss compared
with the initial baseline images
is seen due to remaining circu-
lating contrast agent
Fig. 2 Spin-echo EPI dynamic
susceptibility contrast imaging.
A series of raw images during
the passage of a bolus of gado-
linium is displayed. The signal
drop is identical in the temporal
evolution; the degree of 
signal drop is, however, less
pronounced compared to Fig. 1
(gradient-echo)
bed. Recirculation phenomena rapidly dilute the passing
Gd bolus. The measured MR signal intensity change vs
time curve is converted into a contrast agent tissue con-
centration vs time curve (Fig. 3). Both empirical and the-
oretical studies have shown that the degree of signal
drop in a voxel is directly related to the amount of con-
trast agent in that voxel [9, 11]. This relationship be-
tween the measured signal change over time and the con-
centration of contrast agent in a voxel over time is the
key link that allows calculations of cerebral haemody-
namics. This non-invasive technique for measuring cere-
bral perfusion was first used by Villringer et al. in 1988
[12]. The mathematical algorithms used to calculate the
haemodynamic data are similar to the indicator or tracer
dilution methods developed at the end of the nineteenth
century [13, 14]. PWI uses a simple extension of this
principle: if one compares the signal intensity of voxels
before and after the injection of a known amount of con-
trast agent, the signal change can only be due to the ad-
dition of the contrast agent. Because the signal drop is
directly related to the concentration of the Gd in the
blood pool, CBV can be calculated by knowing the
amount of Gd that was injected.
MR sequences in dynamic susceptibility 
contrast imaging
The primary goal of susceptibility MRI is to generate a
T2/T2* signal vs time graph by measuring a maximum
of data points during the first passage of the contrast
agent. Echo-planar (EPI) sequences are typically used
because the short acquisition time (<100 ms) per slice al-
lows acquiring a large number of images per time period
at multiple locations.
Echo-planar techniques can be combined both with
T2-weighted spin-echo (SE) and T2*-weighted gradient-
echo (GE) sequences (Figs. 1, 2). The SE sequences
have been proven to be more advantageous than GE se-
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Fig. 3 Normal signal-vs-time graph in a voxel within the central
grey matter. Each data point represents the signal intensity mea-
sured within the voxel in time. Error bars indicate the standard
deviation. The curve is characterized by a baseline region that is
ended by the arrival point of contrast agent with a sharp decline of
the signal intensity. The signal drop recovers quickly after a peak
signal change as the bolus washes out of the brain. A second,
small signal drop results from the first bolus recirculation. The
post-injection signal intensity remains somewhat lower compared
with the initial baseline signal intensity due to residual, recirculat-
ing contrast agent. The signal-vs-time curve is then transformed
into a concentration-vs-time curve or ∆R2-vs-time curve by taking
the negative log of the signal change. Cerebral blood volume
(CBV) is calculated from the area underneath the ∆R2 curve. If
the arterial input function is known, cerebral blood flow (CBF)
maps can be calculated. Mean transit time (MTT) maps are calcu-
lated by dividing CBV by CBF. Additional maps are created rely-
ing on different characteristics of this curve, e.g. time-to-peak
(TTP) signal change or full width half maximum (FWHM)
Fig. 4a, b The CBF and CBV maps in a 16-year-old boy. The
maps are calculated on a voxel-by-voxel basis from a GE EPI 
sequence and an SE EPI sequence. Both sequences show a good
discrimination between grey and white matter. In both maps the
CBF and CBV of the grey matter is higher than that of the white
matter. In the normal brain the CBF image appears similar to the
CBV image
quences because of their higher sensitivity for the micro-
vascular perfusion [11, 15]. The microvascular image
weighting brings PWI into a biologically relevant range.
Subtle differences between the blood volume of grey and
white matter (4 vs 2% blood volume) can consequently
be resolved (Figs. 4, 5, 6). The increased specificity for
the microvascular perfusion is, however, accompanied
by a small decrease in the signal-to-noise ratio (SNR).
Increasing doses of Gd can compensate for the SNR re-
duction.
In clinical practice the patient is examined in a stan-
dard head coil with a sequential multislice single-shot
SE or GE EPI acquisition. Images are typically obtained
for 1 min to include precontrast baseline images, to cap-
ture the first passage of the contrast agent and the postin-
jection phase which includes the second signal drop due
to the recirculation of the contrast bolus as well as the
slow recovery of the signal to baseline due to the pro-
gressing dilution of the contrast agent (Fig. 3). Since the
CBV is calculated on the basis of the signal drop relative
to the precontrast baseline, an adequate estimation of the
baseline (signal) is essential. A reliable baseline signal is
best defined by as many images as possible. Depending
on the MRI hardware, each slice is measured up to 80
times. The first passage is usually visible on 10–12 im-
ages (Fig. 3). One simulation study found that 50 or
more images (per slice) increase the SNR substantially
[16]. The number of slices usually ranges between 5 and
20.
Depending on the performance of the MR gradient
systems, the number of slices is limited by the repetition
time (TR). By increasing the number of slices, the TR
will inevitably increase. Long TRs are, however, disad-
vantageous because the SNR will drop and secondly the
passage of the contrast bolus is sampled by fewer imag-
es. On the other hand, to avoid T1-weighting, the TR
should not be too short (e.g. TR <500 ms). Currently, a
TR of 1500 ms is thought to be a good compromise. The
echo time (TE) should be a balance between an adequate
T2-weighting and sufficient T2 signal. Currently, a TE is
advised between 60 and 75 ms. The slice thickness may
vary between 5 and 10 mm, the field of view between
200 and 240 mm and the acquisition matrix between
128×128 and 256×256. As with any parameter, the ap-
propriate value is a balance or compromise between ad-
vantages and disadvantages. The parameter should be
optimized for the available field strength, gradient per-
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Fig. 5a, b The MTT, TTP, bolus arrival time and FWHM maps in
a 16-year-old boy. These maps are calculated from different char-
acteristics from the ∆R2-vs-time curve. The MTT and TTP maps
are most frequently used next to CBF and CBV maps. The advan-
tage of these maps is their uniform signal intensity. Small changes
are easily identified, which can go undetected on CBF and CBV
maps
Fig. 6 The CBF, CBV and MTT maps in a healthy 8-year-old
child. The CBF and CBV is larger in the grey matter than in the
white matter. The internal capsule is easily differentiated from the
adjacent basal ganglia. The cortex is well perfused. The CBF and
CBV maps should be symmetrical and identical
formance, region of interest, suspected pathology, and
patient characteristics (young child vs adult). In young
children, for instance, the slice thickness should be re-
duced as much as possible (3–4 mm). In addition, the
smaller brain size allows to reduce the field of view
(160–180 mm), consequently increasing the spatial reso-
lution. Currently, no age-specific TR and TE times have
been determined or published.
High field strengths are desirable (1.5 T and higher)
because the SNR will increase and consequently the
haemodynamic maps will be more reliable. The in-
creased SNR is especially favourable in young children.
Perfusion-weighted MRI should always be performed
along with conventional MRI. The short acquisition
times easily allow an integration of PWI in most routine
departmental imaging protocols. PWI should, however,
be performed before contrast-enhanced conventional
MRI sequences are measured. Postcontrast T1-weighted
images can usually follow PWI, as the acquisition times
of PWI are short.
Rationale on magnetic susceptibility 
contrast agents
Susceptibility effects can be induced by using intrinsic or
extrinsic contrast agents. Intrinsic contrast agents are
used in functional MRI to examine brain function [17,
18]. Intrinsic contrast agents can also be used in PWI
(e.g. ASL). A major advantage is that no contrast agents
have to be injected and that the measurements can be re-
peated as often as necessary within the same examina-
tion. A major limitation is that the signal changes are
small (for ASL: of the order of 1–2% at 1.5 T).
The rationale of using an extrinsic contrast agent is to
take advantage of the much larger susceptibility effects
of Gd. The injection of a single dose of Gd (0.1 mmol/kg
body weight) results in an average signal drop of
10–15% at 1.5 T (SE EPI sequences; Fig. 3). The signal
drop can even be enhanced to 20–30% by increasing the
dose to 0.2 mmol/kg (Fig. 7). This greater signal drop
will increase the discrimination between grey and white
matter and will show subtle changes of the cerebral
haemodynamics in early stages of vascular disease.
There is, however, also an upper limit. If the signal de-
crease is greater than 40–50%, additional Gd will de-
crease the quality of the perfusion maps [16].
Magnetic susceptibility contrast agents should be in-
jected as a narrow bolus by a power injector for two rea-
sons. First of all, T2-weighted magnetic susceptibility ef-
fects dominate image contrast only if high intravascular
concentrations of Gd are achieved. Secondly, CBF is cal-
culated from the shape and size of the peak signal drop
vs time curve. A wide bolus might blur slight differences
in arrival time between voxels. By using a bolus as nar-
row as possible, the information extracted from the sig-
nal-vs-time curve can be more accurately translated in a
CBF map. Methods to narrow the bolus of contrast agent
include the use of a power injector with high injection
rates (5 ml/s) and the use of more concentrated contrast
agents or contrast agents with higher magnetic suscepti-
bility effects (e.g. Dysprosium-based agents). In addi-
tion, a fully automated contrast injector allows flushing
the system with a bolus of saline after the Gd injection.
This will advance the remaining Gd within the tubes and
within the patient’s venous system towards the heart.
The use of power injections is not yet established in very
young children. Limited experience is currently avail-
able; most paediatric neuroradiologists favour a manual
injection. The smaller volume of contrast to be injected
in young children and the higher heart rate and faster cir-
culation time are advantageous in children because they
narrow the contrast bolus. This will increases the reli-
ability of the haemodynamic maps.
Dynamic susceptibility contrast imaging relies on an
intact blood-brain barrier (BBB) to keep the contrast
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Fig. 7 Signal-vs-time graphs for different doses of gadolinium.
The larger doses of contrast agent provide a greater signal change;
greater signal changes typically increase the quality of the perfu-
sion maps. Note that the numbers along the y-axis are arbitrary
units displaying the change (loss) in signal intensity during the
passage of the gadolinium
agent intravascularly compartmentalized. In disease pro-
cesses where the BBB is disrupted, the contrast agent
leaks into the brain tissue. The decrease of the compart-
mentalization reduces local field inhomogeneities. In ad-
dition, the extravascular accumulation of contrast agents
causes a local T1 shortening. Both phenomena counter-
act T2-signal decreases from susceptibility effects. Post-
processing algorithms can compensate for moderate de-
grees of BBB leakage [11]. Alternatively, a pre-dose of
0.0025 or 0.005 mmol/kg of Gd can be given 5 min be-
fore the bolus injection. In areas of a disrupted BBB, the
Gd will shorten the T1 relaxation. By using a 5-min de-
lay, the baseline images will already incorporate the sig-
nal change due to the T1 shortening. The passing bolus
of Gd will subsequently reduce the signal proportionally
to T2 susceptibility effects. The predose of Gd compen-
sates for the T1 shortening effects of the leaking Gd, but
cannot, however, overcome the decrease in compartmen-
talization. Finally, the use of Dysprosium chelates, which
display less T1 relaxivity effects while the T2 magnetic
susceptibility effects are more pronounced, partially
compensate for a leaking BBB [19].
Computation of haemodynamic maps
The measured T2 signal intensity–time curve is the start-
ing point of all haemodynamic map calculations (CBV,
CBF, MTT). This curve is available for each voxel with-
in the imaging plane (Fig. 3). The MR signal intensity
curve is converted into a change in 1/T2, or ∆R2-vs-time
curve (Fig. 3). Because ∆R2 and the tissue contrast agent
(e.g. Gd) concentration show a linear relationship
(∆R2=k2 [Gd]), this curve equals a contrast-agent-vs-
time curve. (k2 is a constant that depends on tissue mag-
netic field strength, and MR pulse sequence; [Gd] is the
tissue concentration of gadolinium.)
Maps of CBV (Fig. 4) are calculated by integrating
the area under the ∆R2 curve or concentration–time
curve over time for each pixel. The CBV parameters are
no absolute values but represent relative scalars because
the proportional constant k2 between ∆R2 and absolute
contrast agent concentration cannot be determined with-
out sampling the blood.
The calculation of CBF maps (Fig. 4) require an addi-
tional step. An arterial input function (AIF) has to be
specified which provides information about the timing of
the contrast agent. Typically, another tissue-vs-time curve
within voxels next to the major artery that feeds the tissue
of interest is used as AIF (Fig. 8). In analogy to CBV,
CBF values are relative rather than absolute. Maps of the
mean transit time are rendered by dividing CBV into CBF
(Fig. 5). A number of other “time” maps can be useful, de-
pending on the pathology. These maps are usually simple
to calculate and include maps of the arrival time of the bo-
lus and the time to the peak signal change (TTP; Fig. 5).
All haemodynamic parameters are calculated on a
voxel-by-voxel basis and can be displayed as a grey-
scale map (Figs. 4, 5, 6). The CBV and CBF maps show
a cortico-medullary differentiation due to the differences
in CBV and CBF between grey and white matter. The
MTT maps can be helpful as lesion conspicuity is in-
creased due to the more uniform appearance.
There are a number of potential difficulties related to
the AIF of which one should be aware. The AIF can be in-
fluenced by variations in injection conditions and patient
physiology. Delays and dispersion of the contrast bolus
that occur during the passage of the bolus from the site of
AIF measurement to the tissue of interest as well as partial-
volume effects at the site of AIF measurement can intro-
duce an error in the calculation of CBF. Furthermore, the
tracer kinetic model assumptions of perfusion that are used
for normal perfused brain tissue may be invalid in cerebral
ischaemia. Consequently, perfusion maps should always be
encountered with caution, in particular when absolute
quantification is attempted. The reliability of absolute
quantifications is determined by the quality of the AIF. De-
convolution methods are currently under investigation to
circumvent these limitations to provide reliable absolute
quantifications [20, 21]. PWI is, however, very effective in
the identification of regions with abnormal perfusion.
Arterial spin labelling
Arterial spin labelling (ASL) generates absolute haemo-
dynamic parameter by labelling or tagging arterial spins.
Inflowing blood water magnetization is inverted or satu-
rated by a radio-frequency pulse before entering the
brain slice of interest. After waiting an appropriate time
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Fig. 8 Normal signal-vs-time graph in voxels along the right mid-
dle cerebral artery (MCA) for a GE EPI and SE EPI sequence.
These curves are used as arterial input function to calculate CBF.
The signal drop is larger for GE EPI sequences compared with SE
EPI sequences
interval, the labelled, inverted or saturated arterial blood
spins enter the brain slice of interest and decrease the
overall magnetization of this slice. The inflow of la-
belled spins generally produces a signal change of 1–2%.
The degree of signal change is directly related to the
CBV and CBF [22, 23].
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Fig. 9a–c A 1-day-old male (39 weeks of gestation) with acute
neonatal stroke. The child presented with tonic clonic seizures at
24 h of age. a An extensive, wedge-shaped left MCA stroke is
seen on T2-weighted fast-spin-echo (FSE) images. The lesion is
barely seen on the fluid-attenuated inversion recovery (Flair) se-
quence. b The lesion is markedly hyperintense on isotropic diffu-
sion-weighted images (DWI) and hypointense on the apparent dif-
fusion coefficient (ADC) maps indicating acute neonatal stroke
with decreased diffusion. The left posterolateral thalamus is also
involved. c The perfusion maps show a decreased CBF, slightly
increased CBV and a prolonged MTT/TTP matching the area of
diffusion abnormality. No additional areas of perfusion abnormali-
ties are encountered
Arterial spin labelling techniques measure steady-
state tracer levels by using the T1 magnetization state of
the arterial spins themselves as a freely diffusible tracer.
This has two advantages. First of all, steady-state meth-
ods allow multiple measurements or averaging periods to
boost the SNR. Secondly, the free diffusion characteris-
tics of the “tracer” give us in analogy to the magnetic
susceptibility contrast techniques microvascular-weight-
ed information. As soon as the labelled spins reach the
brain slice of interest, the labelled spins diffuse into the
extracellular space and interact with tissue spins or basi-
cally the tissue water.
The signal changes can be displayed by subtracting
the image after spin labelling from a control image be-
fore spin labelling. The recorded signal changes are di-
rectly related to the CBF and CBV. Consequently, abso-
lute CBV and CBF parameters are calculated. Additional
advantages of ASL are the insensitivity to susceptibility
artefacts which enhances the reliability of measurements
near the skull base and the possibility to selectively label
arteries by unilateral or localized labelling coils. This al-
lows examination of different vascular territories inde-
pendently which can be used to evaluate the functional
efficiency of collateral vascular supplies. A major disad-
vantage is the low signal change (1–2%) and conse-
quently the low SNR that requires long acquisition times
(up to 10 min), making the technique susceptible for mo-
tion artefacts. This can be especially troublesome in chil-
dren. Only few reports are available on the use of ASL in
children [24].
Perfusion-weighted imaging in children
Cerebrovascular disease (CVD) in children includes pri-
mary (e.g. acute embolic stroke, primary vasculopathies,
arteriovenous malformations) and secondary vascular
disorders (e.g. sickle cell disease, metabolic diseases,
collagen vascular disorders, inflammatory/para-inflam-
matory conditions). In secondary disorders, the cerebro-
vascular system is not the primary site of pathology but
gets affected during the disease course. Secondary CVD
in children tend to be more often thrombotic than embol-
ic [25].
Because CVD is more prevalent in children than pre-
viously thought, [25] and represents a significant source
of morbidity and mortality [25], the need for a minimally
invasive and reliable haemodynamic imaging tool is ob-
vious. The non-invasive character of PWI, the suscepti-
bility for microvascular haemodynamic alterations, the
short acquisition times, the lack of ionizing radiation and
the presently widespread availability of MRI scanners
make PWI ideally suited for children. In addition, the
faster heart rate, the smaller total blood volume and the
smaller size of the brain in children are advantageous.
PWI can easily be added to conventional MRI integrat-
ing conventional–anatomical and functional–haemody-
namic data (Figs. 9, 10, 11, 12, 13).
The indications for PWI in children are similar to
those in adults. Most experience has thus far been col-
lected for cerebrovascular occlusive diseases (cerebral
ischaemia) and for intracranial neoplasm (e.g. tumour
grading, differentiation between tumour recurrence and
radiation necrosis). Other potential applications include
hypoxic ischaemic encephalopathy or perinatal asphyxia,
near drowning, intoxications, metabolic diseases, head
trauma, migraine, epilepsy and any kind of cerebral dis-
ease that is accompanied by changes in the cerebral
haemodynamics.
Perfusion-weighted MRI studies can possibly provide
more insight into the understanding of the normal and
pathological development and maturation of the brain.
Furthermore, PWI could give important data about tu-
mour angiogenesis allowing a better understanding of tu-
mour growth and the presumed relation between perfu-
sion and malignancy grade. PWI can also be used to
guide and monitor treatment.
Developmental changes 
of cerebral haemodynamics in children
Knowledge about the normal pattern of brain perfusion
as well as normal values of brain perfusion in the devel-
oping brain are essential for interpreting disease-related
changes in cerebral perfusion. Because the child’s brain
is subject to a continuous maturation, perfusion values
are expected to change during the progressing myelin-
ation/maturation. Currently, limited PWI results are
available; most information has been extracted from PET
and SPECT studies [26, 27].
Tokumaru et al. [26] studied the 123I-IMP uptake in
the developing brain by SPECT. Their study showed that
changes in 123I-IMP uptake parallel both temporally and
topographically the changes in T1 and T2 relaxation
times due to progressing myelination confirming the
tight relation between cerebral perfusion and myelination
as postulated by von Monakow at the beginning of the
past century [28].
The change in the regional distribution and magnitude
of perfusion in the maturing brain likely reflects the ana-
tomic evolution of the cerebral vasculature. This process
appears to be markedly influenced by the brain’s func-
tional and metabolic status. As neurons or neuronal cen-
ters approach maturity, they recruit an increasingly rich
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Fig. 10a–c A 19-month-old
boy with severe anoxic brain
injury due to prolonged cardiac
arrest. a Conventional MRI
shows a discrete T2-hyperin-
tensity within the posterior as-
pects of both lentiform nuclei
and thalami. b The lesions are
DWI hyperintense with associ-
ated ADC hypointensity indi-
cating decreased diffusion.
c Haemodynamic imaging re-
veals an increased CBV and
CBF (MTT consequently un-
changed) related to post-isch-
aemic hyperaemia
capillary network [29]. High blood flow is seen in my-
elinating and myelinated areas of the brain during the
neonatal period that may reflect the increased energy de-
mands of the biosynthetic processes associated with pro-
gressing myelination [30, 31]. Blood flow to the white
matter has been shown to be much higher during matura-
tion than at completed maturation. These findings support
the theory that progressing myelination increases the met-
abolic demand and consequently the CBF [30]. Another
explanation is that myelination, CBF and cerebral meta-
bolic rates are all related to increasing activity in specific
regions of the brain that are functionally important during
specific developmental periods [26]. Takahashi et al. [27]
found that CBF is lower in the neonatal period than in
older children and adults, increases significantly during
early childhood with a peak around 7 years and finally
gradually reaches adult values during adolescence. They
also showed age-dependent regional differences in cere-
bral perfusion. The last area in which the cerebral perfu-
sion increases appeared to be the frontal association cor-
tex, whereas the cerebral perfusion was prominent in the
occipital lobe in every age group. The dynamic changes
in cerebral perfusion parallel the physiological develop-
mental state within the different brain areas.
Ball and Holland [25] evaluated more than 1000 PWI
examinations performed in children between 6 days and
18 years. The normal grey-to-white-matter CBV ratio
ranged between 3 and 4:1. Higher ratios were seen in
children under 2–3 years of age. In healthy children,
CBV, CBF and MTT maps should always be symmetri-
cal for both hemispheres (Fig. 6).
PWI in cerebral ischaemia
Perfusion-weighted MRI has proved its value in acute
cerebral ischaemia [6]. Diffusion-weighted MRI (DWI)
identifies tissue injury (cytotoxic oedema) within min-
utes after ischaemia [32]. PWI in combination with DWI
can detect critical cerebral hypoperfusion before neuro-
nal cell injury becomes irreversible and can identify tis-
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Fig. 11a–d A 12-year-old boy with sickle cell disease. On the day
of MRI a third stroke event occurred with mild right-sided weak-
ness and severe language defects. a Conventional MRI including
T2 FSE and contrast-enhanced T1 SE imaging showed a discrete
T2 FSE hyperintensity within the left frontal, parietal and insular
cortical regions as well as a discrete leptomeningeal, sulcal en-
hancement. b The DWI shows multiple hyperintense, ischaemic
lesions with decreased diffusion in the previously mentioned loca-
tions. c The CBF and CBV maps reveal a large area of hypoperfu-
sion involving the left ACA and MCA territories. The MTT is
markedly prolonged. The mismatch between DWI and PWI abnor-
mality indicates tissue at risk for future infarction. d Follow-up
imaging several months later showed a new, subacute T2 FSE hy-
perintense ischaemia within the area of initial hypoperfusion de-
spite several blood transfusions
sue at risk for future infarction. The combination of DWI
and PWI allows discrimination between the core of in-
farction and the ischaemic penumbra. The core most
probably represents irreversibly injured tissue, whereas
the penumbra is believed to represent ischaemic but via-
ble brain tissue [33]. Schlaug et al. [34] hypothesized
that the ischaemic penumbra can be defined operational-
ly by correlating the area of initial diffusion abnormality
with the area of hypoperfusion on PWI. Matching areas
of DWI and PWI abnormalities are considered as a pos-
sible imaging correlate to the core of the infarction,
whereas a DWI/PWI mismatch (PWI>DWI) is consid-
ered to correlate with the ischaemic penumbra (Figs. 9,
10, 11) [34]. Major advantages are that treatment can be
started before tissue injury is irreversible, infarct pro-
gression can be limited, and possible preventive treat-
ments for tissue at risk for infarction can be considered.
Perfusion-weighted MRI can also be of importance to
identify spontaneous reperfusion [6]. Reperfusion can
save ischaemic but viable, temporarily hypoperfused
brain tissue. Reperfusion is, however, also thought to be
associated with secondary injury to the brain [35]. So-
called reperfusion injury with decoupling of CBV, CBF
and metabolic rate can be the target of neuroprotective
treatments. Reperfusion injury is believed to be related
to secondary injury in perinatal asphyxia [35].
One of the most important contributions of PWI in
the management of children with acute neurological def-
icits is to rule out cerebral ischaemia. In most cases of
acute neurological symptoms, cerebral ischaemia is in-
cluded in the differential diagnosis despite the fact that
many other diseases can present with acute deficits. Be-
cause conventional MRI can be misleading in the early
stages of ischaemia and a possible delay in starting treat-
ment can have far-reaching consequences, the exclusion
of acute cerebral ischaemia by PWI/DWI is as valuable
as the identification of cerebral ischaemia.
Finally, PWI may also be helpful in differentiating ve-
nous from arterial infarction. In venous infarction, an ar-
terial deficit may be absent, whereas in arterial occlusion
an arterial deficit is always present. In addition, the sig-
nal recovery due to the passage of Gd is markedly de-
layed in venous infarction, whereas this delay can be ab-
sent in arterial infarction [25, 36].
PWI in primary or secondary cerebral 
vasculopathies
Moya-Moya disease is one of the most frequent and best-
known primary cerebral vasculopathy in children with
chronic progressive, large vessel obstructive disease. Sec-
ondary vasculopathies in children include homozygous
sickle cell disease (Fig. 11), idiopathic vasculitis, second-
ary vasculitis and various metabolic diseases.
Perfusion-weighted MRI is very important in evaluat-
ing the cerebral haemodynamics especially concerning
possible collateral circulations. PWI may reveal the col-
lateral perfusion, give information about the significance
of this collateral supply and possibly predict the likeli-
hood of the haemodynamic success of a bypass.
Perfusion-weighted MRI has been proven to be useful
in the diagnosis and follow-up of children with Moya-
Moya disease [37, 38, 39]. In the initial presentation, an
increased flow in the basal ganglia next to perfusion defi-
cits and altered transit times within the cortex are ob-
served. In the late stadium, PWI is helpful in assessing the
chronic hypoperfusion. In contrast to SPECT, PWI allows
to determine if the remaining cerebral perfusion results
from the great cerebral arteries or from collaterals. The re-
construction of perfusion maps, especially CBF maps, can
be difficult. The progressive stenosis of the great cerebral
arteries makes it difficult to find a reliable AIF.
PWI in cerebral tumours
Several studies in adult patients have linked tumour
grade with changes in CBF. One study indicated that tu-
mours with any regional CBV value over twice that of
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Fig. 12a, b An 11-year-old girl with a low-grade astrocytoma.
a Conventional MRI revealed a hypothalamic/chiasmatic astrocy-
toma. The lesion is slightly T1 hyperintense due to an intra-lesio-
nal haemorrhage. b The lesion is both DWI and ADC hyperin-
tense with a hypointense peripheral ring that results from suscepti-
bility effects related to the intra-lesional haemorrhage. The low
CBV and CBF map values are consistent with the low malignancy
grade of the tumour. The haemodynamic maps have been correct-
ed for a possible leaky blood-brain barrier
the white matter have a high likelihood of having high-
grade components, whereas tumours with maximum
CBV values less that of 1.5 times white matter are usual-
ly low grade [40]. Since maps of CBF have become
available only recently, few studies have focused on cor-
relating CBF with tumour grade. Initial results indicate a
similar relation between CBF and tumour grade [41].
These links between tumour grade and cerebral haemo-
dynamics could, however, not yet be reproduced for pae-
diatric brain tumours (Figs. 12, 13). Ball and Holland re-
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Fig. 13a–c A 16-year-old girl with a fourth ventricle haemangio-
blastoma. a Conventional MRI shows a T2-hyperintense, contrast-
enhancing midline tumour within the region of the foramen of 
Magendie. Multiple, enlarged tumour vessels within the tumour
and within the adjacent cerebro-pontine cisterns are seen. b The
tumour is DWI hypointense and ADC slightly hyperintense. c The
CBV and CBF values are markedly increased due to the high vas-
cularity of the tumour. The MTT is also increased
ported similar CBF values for pilocytic astrocytomas and
medulloblastomas [25].
Most authors agree over the value of PWI in differen-
tiating tumour recurrence from complications of radia-
tion therapy or chemotherapy. Imaging findings can be
indistinguishable on conventional MRI [42]. PWI can,
however, distinguish between radiation necrosis and via-
ble tumour. Tumour tissue will show normal or increased
haemodynamic parameter (CBV), whereas radiation ne-
crosis is characterized by decreased CBV values [43].
Similar reductions in CBV are encountered in tissue in-
jury and necrosis related to chemotherapy [44].
Brain tumours often display different grades of malig-
nancy in different areas of the tumour bulk. Correct tu-
mour grading relies on the biopsy of the tumour compo-
nents with the highest grade of malignancy. Haemody-
namic maps can be helpful in directing biopsies to the
areas of highest malignancy (increased CBV) [45]. Cur-
rently, no prospective studies have been published in
paediatric brain tumours.
One of the most exciting fields of active research in
haemodynamic imaging of brain tumours is focused on
characterizing tumour angiogenesis. Angiogenesis refers
to the ability of tumours to induce the proliferation of
new blood vessels (neovascularization). Angiogenesis is
believed to play an important role in the growth and
spread of cancer. Once a malignant cell transformation
has occurred, every increase in tumour cell population
must be preceded by an increase in new capillaries con-
verging to the tumour [46, 47].
Tumour vessels differ from vessels in normal tissue
both qualitatively and quantitatively. Tumour vessels are
usually disorderly and often large, dilated and tortuous
with increased distances between the separate vessels. In
addition, average tumour vessels have diameters two to
three times that of normal tissue. Furthermore, during the
initial formation of the tumour vascular bed, capillary
sprouts and blind-ended microaneurysm-like saccular ves-
sels are observed at the tumour margins. With the progress-
ing evolution of the vascular bed and progressing tumour
size, these buds anastomose to other new vessels with con-
tinuous increase of vessel size [48, 49]. The microvascular
architecture and the disorganization of neovascularity with
multiple blind-ending vessels and other morphological
changes are believed to be responsible for significant mis-
matches between CBF and CBV in tumours. These mis-
matches can represent a biomarker of disorganization and
tumour malignancy. The CBF–CBV mismatch possibly
correlates with how many angiogenic vessels are present,
since many angiogenic vessels are blind ending.
Techniques which could serially evaluate angiogene-
sis non-invasively would be extremely valuable to better
understand tumour growth, tumour expansion, and pro-
gressing tumour vascularization. In addition, the results
from anti-angiogenic therapeutic agents or treatments
could be monitored, thereby providing insight into why
anti-angiogenic therapy succeeds or fails.
Few angiogenesis-specific imaging tools are currently
available. Preliminary data suggest that the distribution of
capillary size can be extracted from PWI techniques.
Spin-echo PWI sequences show a significant degree of
microvascular weighting compared with a more uniform
vessel size dependence seen on GE PWI sequences. In
other words, the degree of flow-related signal changes on
SE EPI sequences depends on the vessel size, whereas sig-
nal changes on GE sequences are less dependent on the
vessel size [50]. This difference in signal decay can be
used to determine average capillary diameter in a voxel
[51]. The ratio of the change in T2* and T2 relaxation rate
increases nearly linearly with vessel size and therefore
may provide an indication of the average vessel size with-
in a voxel allowing to measure the degree of angiogenesis.
This information can be achieved by interleaving a SE
with a GE sequence during a single injection of contrast
agent. Next to the possibility of mapping vessel size distri-
bution, CBV and CBF can easily be measured by PWI.
Consequently, PWI could serve as a promising technique
to visualize tumour angiogenesis, and can consequently be
used to monitor anti-angiogenic therapies in the future.
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